|
1
|
Melosky B: Advanced typical and atypical
carcinoid tumours of the lung: Management recommendations. Curr
Oncol. 25:S86–S93. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rindi G, Klersy C, Inzani F, Fellegara G,
Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM,
Galetta D, et al: Grading the neuroendocrine tumors of the lung: An
evidence-based proposal. Endocr Relat Cancer. 21:1–16.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ventura L, Gnetti L, Silini EM, Rindi G,
Carbognani P, Rusca M and Ampollini L: Primary atypical carcinoid
tumor of the mediastinum: A very rare finding. J Thorac Dis.
9:367–372. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Strosberg JR, Berry MF and Tanzelaar HD:
Thymic neuroendocrine (carcinoid) tumors. UpToDate. https://www.uptodate.com/contents/thymic-neuroendocrine-carcinoid-tumors.
Jul 23, 2019.
|
|
5
|
Gielda BT, Peng R, Coleman JL, Thomas CR
and Cameron RB: Treatment of early stage thymic tumors: Surgery and
radiationtherapy. Current treatment options in oncology. 9:259–268.
2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wick MR, Scott RE, Li CY and Carney JA:
Carcinoid tumor of the thymus: A clinicopathologic report of seven
cases with a review of the literature. Mayo Clin Proc. 55:246–254.
1980.PubMed/NCBI
|
|
7
|
Tiffet O, Nicholson AG, Ladas G, Sheppard
MN and Goldstraw P: A clinicopathologic study of 12 neuroendocrine
tumors arising in the thymus. Chest. 124:141–146. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vinik AI, Silva MP, Woltering EA, Go VLW,
Warner R and Caplin M: Biochemical testing for neuroendocrine
tumors. Pancreas. 38:876–889. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lin FCF, Lin CM, Hsieh CC, Li WY and Wang
LS: Atypical thymic carcinoid and malignant somatostatinoma in type
I multiple endocrine neoplasia syndrome: Case report. Am J Clin
Oncol. 26:270–272. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
John LC, Hornick P, Lang S, Wallis J and
Edmondson SJ: Giant thymic carcinoid. Postgrad Med J. 67:462–465.
1991.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fukai I, Masaoka A, Fujii Y, Yamakawa Y,
Yokoyama T, Murase T and Eimoto : Thymic neuroendocrine tumor
(thymic carcinoid): A clinicopathologic study in 15 patients. Ann
Thorac Surg. 67:208–211. 1999.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dutta R, Kumar A, Julka PK, Mathur SR,
Kaushal S, Kumar R, Jindal T and Suri V: Thymic neuroendocrine
tumour (carcinoid): Clinicopathological features 188 of four
patients with different presentation. Interact Cardiovasc Thorac
Surg. 11:732–736. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gal AA, Kornstein MJ, Cohen C, Duarte IG,
Miller JI and Mansour KA: Neuroendocrine tumors of the thymus: A
clinicopathological and prognostic study. Ann Thorac Surg.
72:1179–1182. 2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Garg R, Bal A, DAS A, Singh N and Singh H:
Proliferation marker (Ki67) in sub-categorization of neuroendocrine
tumours of the lung. Turk Patoloji Derg. 35:15–21. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Caplin ME, Baudin E, Ferolla P, Filosso P,
Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A and Rossi RE:
Pulmonary neuroendocrine (carcinoid) tumors: European
neuroendocrine tumor society expert consensus and recommendations
for best practice for typical and atypical pulmonary carcinoids.
Ann Oncol. 26:1604–1620. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Filosso PL, Guerrera F, Evangelista A,
Welter S, Thomas P, Casado PM, Rendina EA, Venuta F, Ampollini L
and Brunelli A: Prognostic model of survival for typical bronchial
carcinoid tumours: Analysis of 1,109 patients on behalf of the
European Association of Thoracic Surgeons, (ESTS) Neuroendocrine
Tumours Working Group. Eur J Cardiothorac Surg. 48:441–447.
2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Franco R, Marino FZ and Giordano A: The
Mediastinal Mass-A multidisciplinary approach: 2018. Springer
Link.
|
|
18
|
Fazio N, Grana C, Pelosi G, Torrisi R, Di
Meglio G, Tradati N, Lorizzo K and De Braud F: Successful
chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly
aggressive neuroendocrine carcinoma. Acta Oncol. 45:627–629.
2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Furuta M, Hayakawa K, Kato S, Mitsuhashi
N, Nakajima T and Niibe H: Malignant neuroendocrine tumor
presenting a huge mediastinal mass controlled with radiation
therapy. Lung cancer. 22:55–58. 1998.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kriegsmann M, Muley T, Harms A, Tavernar
Goldmann T, Dienemann H, Herpel E and Warth A: Differential
diagnostic value of CD5 and CD117 expression
in thoracic tumors: A large scale study of 1,465 non-small cell
lung cancer cases. Diagn Pathol. 10(210)2015.PubMed/NCBI View Article : Google Scholar
|
